| 摘要 |
A therapeutic agent for treatment of acute lung injury, especially acute respiratory distress syndrome and adult respiratory distress syndrome, resulting from indirect causes, especially the sepsis syndrome, severe nonthoracic trauma, hypertransfusion during emergency resuscitation, and an artificial cardiopulmonary bypass surgery, and a therapeutic agent for hypoxemia in acute lung injury, said agents comprising anti-IL-8 antibody as an active ingredient. |
